Application of CRISPR/Cas9 Pooled Screening for a Non-immediate Readout Model

2024-01-01
Linking phenotypes to genetic components has been an essential part of novel drug discovery, and screening methods have been widely employed to achieve such a goal. Screens can be conducted in either pooled or arrayed formats. Although arrayed screenings provide a better and cheaper alternative in small scale, the larger-scale screenings are conducted in pooled manner. With its adaptability to various models and conditions, CRISPR/Cas9 technology provides an invaluable alternative to classical and RNAi-based screening methods. Combined with high-throughput sequencing and bioinformatics, CRISPR-/Cas9-based pooled screening methods provide unbiased and robust data. In this protocol, we employed CRISPR-/Cas9-based pooled screening for a non-binary and non-immediate readout.
Methods in molecular biology (Clifton, N.J.)
Citation Formats
N. Terzi Çizmecioğlu, “Application of CRISPR/Cas9 Pooled Screening for a Non-immediate Readout Model,” Methods in molecular biology (Clifton, N.J.), vol. 2849, pp. 87–116, 2024, Accessed: 00, 2024. [Online]. Available: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=85199224188&origin=inward.